Related Experiment Video
Updated: Jun 5, 2026

13:01
Mammary Transplantation of Stromal Cells and Carcinoma Cells in C57BL/6J Mice
Published on: August 12, 2011
Concurrent breast stroma sarcoma and breast carcinoma: a case report
Ramon Andrade de Mello1, Paulo Figueiredo, Mariela Marques
1Department of Medical Oncology, Instituto Português de Oncologia de Coimbra, Francisco Gentil, Avenida Bissaya Barreto, 98, 3000-075, Coimbra, Portugal. ramondemello@gmail.com.
Journal of Medical Case Reports
|December 25, 2010
Summary
This case study details a rare instance of a 42-year-old woman diagnosed with bilateral breast cancer, featuring two distinct histological types: invasive mammary carcinoma and mammary stroma sarcoma. The successful treatment highlights the possibility of managing such complex cases.
Area of Science:
- Oncology
- Pathology
Background:
- Breast cancer is a significant global health concern affecting numerous women worldwide.
- Bilateral breast cancer, occurring in both breasts, is uncommon and typically involves tumors of the same histological type.
- Concurrent bilateral breast cancer with distinct histological types is exceptionally rare.
Purpose of the Study:
- To report a rare case of simultaneous bilateral breast cancer with two different histological types: invasive mammary carcinoma and breast sarcoma.
- To describe the diagnostic and treatment approach for this unique clinical presentation.
Main Methods:
- A 42-year-old woman presented with distinct breast nodules, diagnosed via biopsy as invasive mammary carcinoma (right breast) and sarcoma (left breast).
- The patient underwent bilateral modified radical mastectomy, followed by chemotherapy (5-fluorouracil, epirubicin, cyclophosphamide) and radiotherapy.
- Hormone receptor-positive invasive mammary carcinoma was treated with tamoxifen and subsequently letrozole.
Main Results:
- Histological examination confirmed invasive mammary carcinoma (grade II lobular pleomorphic type) with axillary lymph node involvement in the right breast.
- A mammary stroma sarcoma, negative for epithelial biomarkers and positive for vimentin, was identified in the left breast.
- The patient completed treatment with no signs of disease progression at the last follow-up.
Conclusions:
- The annual risk of bilateral breast cancer is approximately 1%, with a higher incidence in lobular histology.
- This case underscores the occurrence of simultaneous, histologically distinct bilateral breast tumors, representing a rare clinical scenario.